Acarbose and cytolytic hepatitis Patient Reports February 11, 2012

Acarbose Side Effects Report #5306948-8
Acarbose side effect was reported by a Health Professional from FRANCE on Mar 26, 2007. Female patient, 83 years of age, was diagnosed with unevaluable event, deep vein thrombosis  and was treated with Acarbose. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arrhythmia , aspartate aminotransferase increased, cardiac failure, cytolytic hepatitis, lung disorder, vertigo. Acarbose dosage: unknown. During the same period patient was treated with TAHOR, MOGADON, FUROSEMIDE, PREVISCAN, FLECAINIDE ACETATE, ALLOPURINOL, TRIATEC. Patient was hospitalized. Patient recovered.

Acarbose Side Effects Report #5391160-7
Acarbose side effect was reported by a Physician from FRANCE on July 13, 2007. Female patient, 83 years of age, was diagnosed with unevaluable event, deep vein thrombosis  and was treated with Acarbose. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, lung disorder. Acarbose dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, MOGADON, FUROSEMIDE, PREVISCAN, FLECAINIDE ACETATE, ALLOPURINOL, TRIATEC. Patient was hospitalized. Patient recovered.

Acarbose Side Effects Report #4751128-8
Acarbose side effect was reported by a Consumer or non-health professional from FRANCE on Aug 11, 2005. Female patient, 49 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, arthralgia and was treated with Acarbose. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, pulmonary embolism , syncope. Acarbose dosage: unknown. During the same period patient was treated with KLIPAL, GLUCOPHAGE, DOLIPRANE, HEMEOPATIC TREATMENT, FRAXIPARINE. Patient was hospitalized. Patient recovered.

Acarbose Side Effects Report #4823827-0
Acarbose side effect was reported by a Consumer or non-health professional from FRANCE on Oct 24, 2005. Female patient, 60 years of age, weighting 286.6 lb, was treated with Acarbose. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, endoscopy gastrointestinal abnormal, pancreatitis acute, pancreatitis necrotising. Acarbose dosage: 150 MG, TOTAL DAILY, ORAL. During the same period patient was treated with DILTIAZEM, EUPRESSYL, TRIATEC, ZOLOFT, LODALES, MEDIATOR. Patient was hospitalized. Patient recovered.